Factors affecting outcomes in Veterans with low-risk prostate cancer
Multi-level factors impacting clinical outcomes in Veterans with low-/intermediate-risk prostate cancer
This study is looking at how different factors, like your background and health environment, can affect the outcomes for Veterans with low- to intermediate-risk prostate cancer, and it aims to create a helpful tool to identify those who might be at greater risk of their cancer spreading, so they can get more personalized treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Greater Los Angeles Healthcare System NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11052413 on NIH RePORTER |
What this research studies
This research investigates the various factors that influence the clinical outcomes of Veterans diagnosed with low- to intermediate-risk prostate cancer. It focuses on understanding how ancestry, genetic variants, social determinants of health, and environmental exposures may contribute to the risk of metastatic progression in these patients. By analyzing a large cohort of Veterans receiving care within the VA Healthcare System, the study aims to develop a prognostic tool that can help identify patients at higher risk for metastasis. This tool could guide treatment decisions, allowing for more personalized care.
Who could benefit from this research
Good fit: Ideal candidates for this research are Veterans diagnosed with low- to intermediate-risk prostate cancer, particularly those considering active surveillance.
Not a fit: Patients with high-risk prostate cancer or those who have already undergone aggressive treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved risk assessment and tailored treatment strategies for Veterans with low-risk prostate cancer.
How similar studies have performed: Previous research has shown promise in using multi-level factors to predict cancer progression, suggesting that this approach could yield valuable insights.
Where this research is happening
Los Angeles, United States
- VA Greater Los Angeles Healthcare System — Los Angeles, United States (Active)
Researchers
- Principal investigator: Garraway, Isla Pearl — VA Greater Los Angeles Healthcare System
- Study coordinator: Garraway, Isla Pearl
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.